136 related articles for article (PubMed ID: 9210963)
1. Ex vivo antimalarial activity of proguanil combined with dapsone against cycloguanil-resistant Plasmodium falciparum isolates.
Edstein MD; Yeo AE; Shanks GD; Rieckmann KH
Acta Trop; 1997 Sep; 66(3):127-35. PubMed ID: 9210963
[TBL] [Abstract][Full Text] [Related]
2. Multiple-dose kinetics in healthy volunteers and in vitro antimalarial activity of proguanil plus dapsone.
Edstein MD; Veenendaal JR; Rieckmann KH
Chemotherapy; 1990; 36(3):169-76. PubMed ID: 2186899
[TBL] [Abstract][Full Text] [Related]
3. Antimalaria activity of the triple combination of proguanil, atovaquone and dapsone.
Yeo AE; Edstein MD; Rieckmann KH
Acta Trop; 1997 Sep; 67(3):207-14. PubMed ID: 9241385
[TBL] [Abstract][Full Text] [Related]
4. A statistical analysis of the antimalarial activity of proguanil and cycloguanil in human volunteers.
Yeo AE; Edstein MD; Shanks GD; Rieckmann KH
Ann Trop Med Parasitol; 1994 Dec; 88(6):587-94. PubMed ID: 7893172
[TBL] [Abstract][Full Text] [Related]
5. Poor efficacy of antimalarial biguanide-dapsone combinations in the treatment of acute, uncomplicated, falciparum malaria in Thailand.
Wilairatana P; Kyle DE; Looareesuwan S; Chinwongprom K; Amradee S; White NJ; Watkins WM
Ann Trop Med Parasitol; 1997 Mar; 91(2):125-32. PubMed ID: 9307653
[TBL] [Abstract][Full Text] [Related]
6. Activity in vitro of chloroquine, cycloguanil, and mefloquine against African isolates of Plasmodium falciparum: presumptive evidence for chemoprophylactic efficacy in Central and West Africa.
Basco LK; Ringwald P; Thor R; Doury JC; Le Bras J
Trans R Soc Trop Med Hyg; 1995; 89(6):657-8. PubMed ID: 8594688
[No Abstract] [Full Text] [Related]
7. Proguanil polymorphism does not affect the antimalarial activity of proguanil combined with atovaquone in vitro.
Edstein MD; Yeo AE; Kyle DE; Looareesuwan S; Wilairatana P; Rieckmann KH
Trans R Soc Trop Med Hyg; 1996; 90(4):418-21. PubMed ID: 8882194
[TBL] [Abstract][Full Text] [Related]
8. [In vitro sensitivity of Plasmodium falciparum isolates from Gabon to chloroquine and cycloguanil].
Pradines B; Mabika Mamfoumbi M; Keundjian A; Lebeau C; Fusai T; Owono Medang M; Rogier C; Parzy D; Kombila M
Bull Soc Pathol Exot; 1999 May; 92(2):91-4. PubMed ID: 10399596
[TBL] [Abstract][Full Text] [Related]
9. Susceptibility of Plasmodium falciparum to the drugs used to treat severe malaria (quinine) and to prevent malaria (mefloquine, cycloguanil) in Comoros Union and Madagascar.
Randrianarivelojosia M; Randrianasolo L; Randremanana RV; Randriamanantena A; Ratsimbasoa A; Rakotoson JD
S Afr Med J; 2004 Jan; 94(1):47-51. PubMed ID: 14971233
[TBL] [Abstract][Full Text] [Related]
10. Molecular epidemiology of malaria in Yaounde, Cameroon. VI. Sequence variations in the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene and in vitro resistance to pyrimethamine and cycloguanil.
Basco LK; Ringwald P
Am J Trop Med Hyg; 2000 Feb; 62(2):271-6. PubMed ID: 10813484
[TBL] [Abstract][Full Text] [Related]
11. Oxidative activation of proguanil and dapsone acetylation in Thai soldiers.
Edstein MD; Shanks GD; Teja-Isavadharm P; Rieckmann KH; Webster HK
Br J Clin Pharmacol; 1994 Jan; 37(1):67-70. PubMed ID: 8148220
[TBL] [Abstract][Full Text] [Related]
12. The activity of proguanil and its metabolites, cycloguanil and p-chlorophenylbiguanide, against Plasmodium falciparum in vitro.
Watkins WM; Sixsmith DG; Chulay JD
Ann Trop Med Parasitol; 1984 Jun; 78(3):273-8. PubMed ID: 6385887
[TBL] [Abstract][Full Text] [Related]
13. Chlorproguanil-dapsone for malaria in Africa.
Looareesuwan S; Imwong M; Wilairatana P
Lancet; 2004 Jun; 363(9424):1838-9. PubMed ID: 15183616
[No Abstract] [Full Text] [Related]
14. In vitro activity of pyrimethamine, cycloguanil, and other antimalarial drugs against African isolates and clones of Plasmodium falciparum.
Basco LK; Ramiliarisoa O; Le Bras J
Am J Trop Med Hyg; 1994 Feb; 50(2):193-9. PubMed ID: 8116812
[TBL] [Abstract][Full Text] [Related]
15. The chemotherapy of rodent malaria. LXIII. Drug combinations to impede the selection of drug resistance, part 6: the potential value of chlorproguanil and dapsone in combination, and with the addition of artesunate.
Peters W; Stewart LB; Robinson BL
Ann Trop Med Parasitol; 2005 Jul; 99(5):457-72. PubMed ID: 16004705
[TBL] [Abstract][Full Text] [Related]
16. In vitro activities of the biguanide PS-15 and its metabolite, WR99210, against cycloguanil-resistant Plasmodium falciparum isolates from Thailand.
Edstein MD; Bahr S; Kotecka B; Shanks GD; Rieckmann KH
Antimicrob Agents Chemother; 1997 Oct; 41(10):2300-1. PubMed ID: 9333069
[TBL] [Abstract][Full Text] [Related]
17. Concomitant resistance to pyrimethamine and cycloguanil of chloroquine-resistant falciparum malaria from East Africa: an in vitro study of 12 isolates.
Schapira A
Trans R Soc Trop Med Hyg; 1984; 78(3):359-62. PubMed ID: 6380024
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of cycloguanil against African isolates of Plasmodium falciparum.
Basco LK; Ramiliarisoa O; Ringwald P; Doury JC; Le Bras J
Antimicrob Agents Chemother; 1993 Apr; 37(4):924-5. PubMed ID: 8494394
[TBL] [Abstract][Full Text] [Related]
19. Malaria chemoprophylaxis using proguanil/dapsone combinations on the Thai-Cambodian border.
Shanks GD; Edstein MD; Suriyamongkol V; Timsaad S; Webster HK
Am J Trop Med Hyg; 1992 Jun; 46(6):643-8. PubMed ID: 1621888
[TBL] [Abstract][Full Text] [Related]
20. Cycloguanil and its parent compound proguanil demonstrate distinct activities against Plasmodium falciparum malaria parasites transformed with human dihydrofolate reductase.
Fidock DA; Nomura T; Wellems TE
Mol Pharmacol; 1998 Dec; 54(6):1140-7. PubMed ID: 9855645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
